SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052500
Filing Date
2020-11-09
Accepted
2020-11-09 16:10:33
Documents
14
Period of Report
2020-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-8k_20201109.htm   iXBRL 8-K 51267
2 EX-99.1 arna-ex991_6.htm EX-99.1 279540
3 GRAPHIC gyenqgn5klse000001.jpg GRAPHIC 8392
  Complete submission text file 0001564590-20-052500.txt   487306

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20201109.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20201109_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20201109_pre.xml EX-101.PRE 11181
7 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20201109_htm.xml XML 3430
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 201297773
SIC: 2834 Pharmaceutical Preparations